Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol ; 181(5): 3039-48, 2008 Sep 01.
Article in English | MEDLINE | ID: mdl-18713974

ABSTRACT

Immunodominance refers to the restricted peptide specificity of T cells that are detectable after an adaptive immune response. For CD4 T cells, many of the mechanisms used to explain this selectivity suggest that events related to Ag processing play a major role in determining a peptide's ability to recruit CD4 T cells. Implicit in these models is the prediction that the molecular context in which an antigenic peptide is contained will impact significantly on its immunodominance. In this study, we present evidence that the selectivity of CD4 T cell responses to peptides contained within protein Ags is not detectably influenced by the location of the peptide in a given protein or the primary sequence of the protein that bears the test peptide. We have used molecular approaches to change the location of peptides within complex protein Ags and to change the flanking sequences that border the peptide epitope to now include a protease site, and find that immunodominance or crypticity of a peptide observed in its native protein context is preserved. Collectively, these results suggest immunodominance of peptides contained in complex Ags is due to an intrinsic factor of the peptide, based upon the affinity of that peptide for MHC class II molecules. These findings are discussed with regard to implications for vaccine design.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Isoantigens/immunology , Peptides/immunology , T-Cell Antigen Receptor Specificity/immunology , Vaccines , Animals , Epitopes , Histocompatibility Antigens Class II , Mice , Mice, Inbred BALB C , Peptide Fragments/immunology , Proteins/immunology
2.
J Immunol ; 180(3): 1619-33, 2008 Feb 01.
Article in English | MEDLINE | ID: mdl-18209058

ABSTRACT

The MHC-encoded cofactor DM catalyzes endosomal loading of peptides onto MHC class II molecules. Despite evidence from in vitro experiments that DM acts to selectively edit the repertoire of class II:peptide complexes, the consequence of DM expression in vivo, or a predictive pattern of DM activity in the specificity of CD4 T cell responses has remained unresolved. Therefore, to characterize DM function in vivo we used wild-type (WT) or DM-deficient (DM(-/-)) mice of the H-2(d) MHC haplotype and tested the hypothesis that DM promotes narrowing of the repertoire of class II:peptide complexes displayed by APC, leading to a correspondingly selective CD4 T cell response. Surprisingly, our results indicated that DM(-/-) mice do not exhibit a broadened CD4 T cell response relative to WT mice, but rather shift their immunodominance pattern to new peptides, a pattern associated with a change in class II isotype-restriction. Specifically, we found that CD4 T cell responses in WT mice were primarily restricted to the I-A class II molecule, whereas DM(-/-) mice recognize peptides in the context of I-E. The observed shift in isotype-restriction appeared to be due in part to a modification in the peripheral CD4 T cell repertoire available for peptide recognition.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , HLA-D Antigens/genetics , Histocompatibility Antigens Class II/immunology , Immunoglobulin Isotypes/immunology , Amino Acid Sequence , Animals , Cytokines/metabolism , Escherichia coli Proteins/immunology , H-2 Antigens/genetics , H-2 Antigens/immunology , Haplotypes , Histocompatibility Antigens Class II/genetics , Immunodominant Epitopes/immunology , Immunoglobulin Isotypes/genetics , Mice , Mice, Mutant Strains , Molecular Sequence Data , Peptides/chemistry , Peptides/immunology , Periplasmic Binding Proteins/immunology
3.
Expert Rev Vaccines ; 6(3): 357-68, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17542751

ABSTRACT

CD4 T cells play a primary role in regulating immune responses to pathogenic organisms and to vaccines. Antigen-specific CD4 T cells provide cognate help to B cells, a requisite event for immunoglobulin switch and affinity maturation of B cells that produce neutralizing antibodies and also provide help to cytotoxic CD8 T cells, critical for their expansion and persistence as memory cells. Finally, CD4 T cells may participate directly in pathogen clearance via cell-mediated cytotoxicity or through production of cytokines. Understanding the role of CD4 T-cell immunity to viruses and other pathogens, as well as evaluation of the efficacy of vaccines, requires insight into the specificity of CD4 T cells. This review focuses on the events within antigen-presenting cells that focus CD4 T cells toward a limited number of peptide antigens within the pathogen or vaccine. The molecular events are discussed in light of the special challenges that the influenza virus poses, owing to the high degree of genetic variability, unpredictable pathogenicity and the repeated encounters that human populations face with this highly infectious pathogenic organism.


Subject(s)
Antigens, Viral/immunology , CD4-Positive T-Lymphocytes/immunology , Immunodominant Epitopes/immunology , Influenza Vaccines/immunology , Orthomyxoviridae/immunology , Humans
4.
Immunol Rev ; 207: 261-78, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16181342

ABSTRACT

Immunodominance refers to the restricted antigen specificity of T cells detected in the immune response after immunization with complex antigens. Despite the presence of many potential peptide epitopes within these immunogens, the elicited T-cell response apparently focuses on a very limited number of peptides. Over the last two decades, a number of distinct explanations have been put forth to explain this very restricted specificity of T cells, many of which suggest that endosomal antigen processing restricts the array of peptides available to recruit CD4 T cells. In this review, we present evidence from our laboratory that suggest that immunodominance in CD4 T-cell responses is primarily due to an intrinsic property of the peptide:class II complexes. The intrinsic kinetic stability of peptide:class II complexes controls DM editing within the antigen-presenting cells and thus the initial epitope density on priming dendritic cells. Additionally, we hypothesize that peptides that possess high kinetic stability interactions with class II molecules display persistence at the cell surface over time and will more efficiently promote T-cell signaling and differentiation than competing, lower-stability peptides contained within the antigen. We discuss this model in the context of the existing data in the field of immunodominance.


Subject(s)
Antigen Presentation/immunology , HLA-D Antigens/immunology , Immunodominant Epitopes , Models, Immunological , Peptides/immunology , Animals , Antigen-Presenting Cells/immunology , CD4-Positive T-Lymphocytes , Humans , Peptides/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...